INA PHARMS
SpecialtyINA PHARMS is a specialty pharmaceutical company focused on Dermatology.
Upcoming FDA Decisions
Full Calendar →INA PHARMS's Key Drugs
INA PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
INA PHARMS's Recent FDA Approvals
New NDA/BLA approvals for INA PHARMS over the last two years — novel drugs only, excluding generics and label supplements.
INA PHARMS's Therapeutic Areas
INA PHARMS's approved drugs and pipeline span 1 therapeutic area, led by Dermatology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
INA PHARMS's Top Competitors
INA PHARMS's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Baxter, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
INA PHARMS Pipeline Snapshot
Active clinical trials for INA PHARMS across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Dermatology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1963-03-19
- Latest
- 2019-12-26
- Applications
- 3